--- title: "Is It Time To Buy Intuitive Surgical Stock?" description: "Intuitive Surgical (ISRG) stock is considered a worthwhile investment due to its high margins, pricing power, and cash generation capabilities. Despite a 12% decrease in its P/S ratio, the stock has r" type: "news" locale: "en" url: "https://longbridge.com/en/news/268785163.md" published_at: "2025-12-05T16:56:09.000Z" --- # Is It Time To Buy Intuitive Surgical Stock? > Intuitive Surgical (ISRG) stock is considered a worthwhile investment due to its high margins, pricing power, and cash generation capabilities. Despite a 12% decrease in its P/S ratio, the stock has risen 8.9% year-to-date. The company, a leader in robotic-assisted surgery, has seen a 20% increase in procedures and strong recurring revenue. However, historical drawdowns suggest susceptibility to market conditions. The Trefis High Quality Portfolio, which includes ISRG, has outperformed benchmarks, emphasizing the importance of a balanced investment strategy. Money Markets Is It Time To Buy Intuitive Surgical Stock? ByTrefis Team , Contributor. Forbes contributors publish independent expert analyses and insights. Building a platform to do the job of 1 million analysts for Great Speculations Follow Author Dec 05, 2025, 11:37am EST Share Save Comment CHONGQING, CHINA - JULY 19: In this photo illustration, a person holds a smartphone displaying the logo of Intuitive Surgical Inc. (NASDAQ: ISRG), on July 19, 2025 in Chongqing, China. (Photo illustration by Cheng Xin/Getty Images) Getty Images Intuitive Surgical (ISRG) stock may represent a worthwhile investment at present. Why? Because you receive high margins – indicative of pricing power and cash generation capability – at a discounted price. Companies like this yield consistent, predictable profits and cash flows, which mitigate risk and enable capital reinvestment. The market often rewards this approach. Intuitive Surgical is the global leader in robotic-assisted surgery, best known for its da Vinci surgical system, which helps hospitals and surgeons perform minimally invasive procedures with greater precision, efficiency, and safety—driving recurring revenue through instruments, services, and system upgrades. What Is Happening With ISRG ISRG has risen 8.9% thus far this year, yet it is actually 12% cheaper based on its P/S (Price-to-Sales) ratio in comparison to one year ago. Here’s what is going well for the firm. Intuitive Surgical’s stock has increased by 8.9% year-to-date, demonstrating strong operational performance. Q3 2025 experienced a global increase in procedures by 20%, driven by significant adoption of the da Vinci 5 system, with 240 units installed, contributing to an installed base approaching 10,800 systems. This growing base, coupled with 85% recurring revenue from instruments and services, ensures robust cash generation. Management also raised full-year 2025 procedure growth projections to 17-17.5%, which indicates enduring strong demand and pricing power. ISRG Has Strong Fundamentals Recent Profitability: Almost 30.8% operating cash flow margin and 29.3% operating margin LTM. Long-Term Profitability: Approximately 27.8% operating cash flow margin and 26.7% operating margin last 3-year average. Revenue Growth: Intuitive Surgical witnessed a growth of 22.2% LTM and 16.3% last 3-year average, although this is not a growth story. Available At Discount: At P/S multiple of 16.6, ISRG stock is offered at a 12% discount compared to one year ago. Below is a brief comparison of ISRG fundamentals with S&P medians. MORE FOR YOU metrics Trefis \*LTM: Last Twelve Months Don’t Expect A Slam Dunk, Though Although ISRG stock could be an attractive investment opportunity, it is always prudent to consider a stock’s previous drawdown history. ISRG fell by 82% in the Dot-Com crash and 76% during the Global Financial Crisis. The inflation shock led to a decline of nearly 50%, while the Covid sell-off resulted in a drop of around 40%. Even the correction in 2018 caused a 24% decline. The stock exhibits strong fundamentals, but these figures indicate it remains susceptible to adverse market conditions. However, the risk is not restricted solely to significant market crashes. Stocks can decline even during favorable market conditions – consider instances like earnings reports, business updates, or changes in outlook. Read ISRG Dip Buyer Analyses to learn how the stock has bounced back from sharp declines in the past. If you seek further information, examine Buy or Sell ISRG Stock . How We Arrived At ISRG Stock ISRG caught our attention because it satisfied the following criteria: Greater than $10 Bil in market cap High CFO (cash flow from operations) margins or operating margins Significantly declined in valuation over the past one year But if ISRG doesn’t appear attractive to you, here are other stocks that also meet all these criteria: Visa (V) T-Mobile US (TMUS) Salesforce (CRM) Importantly, a portfolio established on 12/31/2016 with stocks that meet the criteria listed above would have performed as follows: Average 12-month forward returns of nearly 19% 12-month win rate (percentage of selections returning positive) of approximately 72% Portfolios Beat Stock Picking Stocks can rise and fall – the secret is to remain invested. A balanced portfolio keeps you in the market, enhances gains, and mitigates single stock risk. The Trefis High Quality (HQ) Portfolio , comprising 30 stocks, has a proven history of comfortably outperforming its benchmark that encompasses all three – the S&P 500, S&P mid-cap, and Russell 2000 indices. What accounts for this? As a category, HQ Portfolio stocks delivered superior returns with lower risk compared to the benchmark index; resulting in a smoother ride, as seen in HQ Portfolio performance metrics . Editorial Standards Reprints & Permissions LOADING VIDEO PLAYER... FORBES’ FEATURED Video ### Related Stocks - [ISRG.US - Intuitive Surgical](https://longbridge.com/en/quote/ISRG.US.md) ## Related News & Research | Title | Description | URL | |-------|-------------|-----| | 直觉外科｜10-K：2025 财年营收 101 亿美元超过预期 | | [Link](https://longbridge.com/en/news/274719864.md) | | 美股盘前热门交易：收入预期低于市场预期，直觉外科盘前跌 3.89% | 直觉外科盘前跌 3.89%；High Roller Tech 盘前涨 358.23%；Lottery.com 盘前涨 86.93%；Inspire Veterinary Partners 盘前涨 72.17%。 | [Link](https://longbridge.com/en/news/272565462.md) | | 人形机器人狂奔 2026：谁为盛宴买单？ | 2026 年春晚展示了四家国产机器人企业的技术成果，标志着中国人形机器人行业的快速发展。宇树科技、松延动力、魔法原子和银河通用的机器人在节目中表现出色，吸引了亿万观众的目光。这场盛宴不仅是技术的展示，更是商业化的关键时刻，企业们希望将知名度 | [Link](https://longbridge.com/en/news/276190831.md) | | 宇树机器人春晚武术表演再炸场，王兴兴：高动态高协同集群控制技术全球首秀 | 宇树科技创始人王兴兴表示，今年机器人的头部激光雷达、灵巧手等硬件和软件做了很多升级，“去年一整年，我们公司包括全中国的机器人的技术提升非常快，像我们公司的话，目前可以做各种的功夫动作，而且在舞台上面我们挑战了很多极限动作，可能一般的人，甚至 | [Link](https://longbridge.com/en/news/276086555.md) | | 智元发布新一代全尺寸人形机器人远征 A3 | 智元机器人于 2 月 13 日发布了新一代全尺寸人形机器人远征 A3，专注于导览导购和文娱商演等人机互动场景。该机器人具备超拟人全身自由度，手臂负载可达 3kg，最高速度为 2m/s，配备灵巧手。其创新的电池嵌入式躯干设计和双电池系统使其在 | [Link](https://longbridge.com/en/news/275868234.md) | --- > **Disclaimer**: This article is for reference only and does not constitute any investment advice.